This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1985 May;102(5):719.

doi: 10.7326/0003-4819-102-5-719.

High-dose cisplatin therapy for cancer of the ovary: neurotoxicity

C M Bagley Jr, R H Rudolph, S E Rivkin, J L Yon Jr

PMID: 4039114
DOI: 10.7326/0003-4819-102-5-719

High-dose cisplatin therapy for cancer of the ovary: neurotoxicity

C M Bagley Jr et al. Ann Intern Med. 1985 May.

. 1985 May;102(5):719.

doi: 10.7326/0003-4819-102-5-719.

Authors

C M Bagley Jr, R H Rudolph, S E Rivkin, J L Yon Jr

PMID: 4039114
DOI: 10.7326/0003-4819-102-5-719

No abstract available

PubMed Disclaimer

Similar articles

Incidence of neuropathy in 395 patients with ovarian cancer treated with or without cisplatin.
van der Hoop RG, van der Burg ME, ten Bokkel Huinink WW, van Houwelingen C, Neijt JP. van der Hoop RG, et al. Cancer. 1990 Oct 15;66(8):1697-702. doi: 10.1002/1097-0142(19901015)66:8<1697::aid-cncr2820660808>3.0.co;2-g. Cancer. 1990. PMID: 2119878 Clinical Trial.
Acute neurological disorders following intraperitoneal administration of cisplatin.
Simkens GA, Hanse MC, de Hingh IH. Simkens GA, et al. Int J Gynaecol Obstet. 2013 Mar;120(3):291. doi: 10.1016/j.ijgo.2012.09.024. Epub 2012 Dec 14. Int J Gynaecol Obstet. 2013. PMID: 23245673 Clinical Trial. No abstract available.
Unexpected incidence of neurotoxicity.
Micha JP. Micha JP. Gynecol Oncol. 1997 Aug;66(2):338-9. doi: 10.1006/gyno.1997.4772. Gynecol Oncol. 1997. PMID: 9264589 No abstract available.
Drugs five years later. Cisplatin.
Loehrer PJ, Einhorn LH. Loehrer PJ, et al. Ann Intern Med. 1984 May;100(5):704-13. doi: 10.7326/0003-4819-100-5-704. Ann Intern Med. 1984. PMID: 6370067 Review.
High-dose cisplatin therapy in ovarian cancer.
Ozols RF, Young RC. Ozols RF, et al. Semin Oncol. 1985 Dec;12(4 Suppl 6):21-30. Semin Oncol. 1985. PMID: 3909419 Review.

See all similar articles

Cited by

Evolution of high-dose cisplatin.
Holleran WM, DeGregorio MW. Holleran WM, et al. Invest New Drugs. 1988 Jun;6(2):135-42. doi: 10.1007/BF00195372. Invest New Drugs. 1988. PMID: 3049431 Review.
Very high-dose cisplatin-induced ototoxicity: a preliminary report on early and long-term effects.
Pollera CF, Marolla P, Nardi M, Ameglio F, Cozzo L, Bevere F. Pollera CF, et al. Cancer Chemother Pharmacol. 1988;21(1):61-4. doi: 10.1007/BF00262741. Cancer Chemother Pharmacol. 1988. PMID: 3342465
Efficacy and safety of high-dose cisplatin and cyclophosphamide with glutathione protection in the treatment of bulky advanced epithelial ovarian cancer.
Di Re F, Bohm S, Oriana S, Spatti GB, Zunino F. Di Re F, et al. Cancer Chemother Pharmacol. 1990;25(5):355-60. doi: 10.1007/BF00686237. Cancer Chemother Pharmacol. 1990. PMID: 2306797
Treatment of non-small-cell lung cancer with vinblastine and very high-dose cisplatin. A Southwest Oncology Group study.
Grunberg SM, Crowley JJ, Livingston RB, Muggia FM, MacDonald JS, Williamson SK, Stephens RL. Grunberg SM, et al. Cancer Chemother Pharmacol. 1991;28(3):211-3. doi: 10.1007/BF00685511. Cancer Chemother Pharmacol. 1991. PMID: 1649706 Clinical Trial.
Cisplatin overdose: toxicities and management.
Tsang RY, Al-Fayea T, Au HJ. Tsang RY, et al. Drug Saf. 2009;32(12):1109-22. doi: 10.2165/11316640-000000000-00000. Drug Saf. 2009. PMID: 19916578 Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
Medical
- MedlinePlus Health Information